CPE News Brief (10.28.2022) – enGene has closed a new round of bridge financing led by Forbion Capital Partners with participation of Fonds de solidarité FTQ and Lumira funds.
Montreal based enGene is a clinical-stage biotechnology company developing non-viral gene therapies based on localized delivery of nucleic acid payloads to mucosal tissues.
Photo by Sangharsh Lohakare on Unsplash